ArianeGroup has successfully carried out the first ignition campaign of the reusable Prometheus® engine on the reusable Themis rocket core stage demonstrator – a key step in providing Europe with the ...
SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces a new Anser® therapeutic drug monitoring (TDM) test for ...
SAN DIEGO, July 31, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the market launch of its proprietary new generation monitoring ...
Saliva-based diagnostic detects genes related to the disease and calculates risk. Prometheus has selected DNA Genotek’s Oragene®•DNA product as the sample-collection kit for MyCeliacID™, a ...
WASHINGTON (AP) -- The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories on Tuesday for a test that could help doctors set drug doses for autoimmune diseases like ...
Prometheus Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease
SAN DIEGO, Aug. 31 Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This ...
The German Aerospace Center (DLR) and the European Space Agency (ESA) have signed a further contract as part of the Prometheus project. The DLR Institute of Space Propulsion at the Lampoldshausen site ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
High court concluded that the patent claims covered laws of nature and were thus invalid. The U.S. Supreme Court delivered a unanimous blow to Prometheus Laboratories by saying that its methods of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results